Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 19 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Time to stop the use of antimicrobials in animal feeds?

The New England Journal of Medicine has recommended that the use of antimicrobials in animal feed is stopped.

News image

fiogf49gjkf04

Three research articles in this week's issue of the journal have investigated the occurrence of antibiotic-resistance bacteria in retail meats.

In the first study, researchers from Maryland, USA, identified and characterized strains of Salmonella isolated from ground meats purchased in the Washington DC area.

The bacterium was isolated from 20% of samples of ground chicken, beef, turkey, and pork purchased at three supermarkets. A total of 13 serotypes were identified.

It was found that 84% of isolates were resistant to at least one antibiotic, and 53% to at least three antibiotics. It was additionally found that 16% of isolates were resistant to ceftriaxone, the drug of choice for treating salmonellosis in children.

Author David G. White, of the Food and Drug Administration, Laurel, said on behalf of his group, "Resistant strains of Salmonella are common in retail ground meats."

"These findings provide support for the adoption of guidelines for the prudent use of antibiotics in food animals, and for a reduction in the number of pathogens present on farms and in slaughterhouses," he concluded.

In the second study, a team from the USA determined the frequency of quinupristin-dalfopristin-resistant Enterococcus faecium in samples of chickens purchased at supermarkets in four states.

The combination of quinupristin and dalfopristin was approved in the United States in late 1999 for the treatment of vancomycin-resistant E. faecium infections.

A related streptogramin, virginiamycin, has been used at subtherapeutic concentrations to promote the growth of farm animals.

Resistant bacteria were isolated from 237 of 407 (58%) chickens sampled.

Antibiotic-resistant bacteria are common in retail meat.
New England Journal of Medicine

In addition, low-level resistance in E. faecium was identified in 3 out of 334 (1%) stool samples from outpatients.

Dr L. Clifford McDonald, of the National Center for Infectious Diseases, Atlanta, Georgia, concluded, "Quinupristin-dalfopristin-resistant E. faecium contaminates a large proportion of chickens sold in US supermarkets.

"However, the low prevalence and low level of resistance of these strains in human stool specimens suggest that the use of virginiamycin in animals has not yet had a substantial influence.

"Foodborne dissemination of resistance may increase, however, as the clinical use of quinupristin-dalfopristin increases."

Antibiotic-resistant enterococci are often present in retail meats, but it is unclear whether the ingestion of these contaminants leads to sustained intestinal carriage.

In the final study, a Danish team investigated this problem.

Resistant strains of Enterococcus faecium, obtained form chicken and pork, were ingested by 12 healthy volunteers. Various concentrations of these same strains were isolated from the stools of all subjects, for up to 2 weeks.

The investigators found that the organisms survived gastric passage and multiplied, and were then transiently present in stool.

N Engl J Med 2001; 345 (16): 1147-54, 1155-60, 1161-6
19 October 2001

Go to top of page Email this page Email this page to a colleague

 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Medication nonadherence and health care costs
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Socioeconomic characteristics in diverticular disease
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Barriers to hepatitis C treatment
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 31 October 2017 
Endoscopic indices of disease activity for Crohn’s
 31 October 2017 
Follow-up of positive results on fecal blood tests
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Fecal microbiota transplantation
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research
 23 October 2017 
NAFLD-related hepatocellular carcinoma in liver resection
 23 October 2017 
Outcome of hepatic sarcoidosis
 20 October 2017 
Hospital readmissions reduction program
 20 October 2017 
Conversion of planned colonoscopy to sigmoidoscopy
 19 October 2017 
Fecal immunochemical tests in colorectal cancer screening
 19 October 2017 
Current management of chylous ascites

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us